Angelo Mario de Mattos, M.D., M.P.H.
|
Philosophy of CareCoinciding with the mission of the Department of Internal Medicine, my goal is to provide excellence in clinical care, research and education, and to deliver high-quality medical care with commitment to cutting-edge research and superior physician training. |
Title: |
Associate Professor |
Specialty: |
Nephrology |
Center/Program Affiliation: |
Transplant Center |
Address: |
UC Davis Medical Center - Cypress Building 2221 Stockton Blvd., Suite C Sacramento, CA 95817 |
Phone: |
(916) 734-2111 |
Other Languages: |
Portuguese, Spanish |
Education: |
Universidade Federal do Rio de Janeiro Rio de Janeiro, Brazil M.D. 1985 |
|
Oregon State University - Portland Portland, Oregon M.P.H. 2004 |
|
|
Colegio Rio de Janeiro Rio de Janeiro, Brazil 1979 |
|
Internships: |
University of Miami Jackson Memorial Medical Center Miami, FL 1990 Internal Medicine Hospital de Clinicas of Universidade Estadual do Rio de Janeiro Rio de Janeiro, Brazil Brazil 1987 Internal Medicine |
Residency: |
University of Miami Jackson Memorial Medical Center Miami, FL 1992 Internal Medicine Hospital dos Servidores do Rio de Janeiro Rio de Janeiro, Brazil Brazil 1989 Nephrology |
Fellowships: |
Oregon Health & Science University Portland, OR 1994 Nephrology and Transplantation Medicine |
Board Certifications: |
American Board of Internal Medicine, Nephrology, 1997 American Board of Internal Medicine, 1993 |
Professional Memberships: |
American College of Physicians American Society of Nephrology International Society of Nephrology Jefferson County Medical Society National Kidney Foundation |
Select Recent Publications: |
Hage FG, Smalheiser S, Zoghbi GJ, Perry GJ, Deierhoi M, Warnock D, Iskandrian AE, de Mattos AM, Aqel RA. Predictors of Survival in Patients with End Stage Renal Disease Evaluated for Kidney Transplantation. American Journal of Cardiology, 100(6): 1020-1025, 2007 Chandrakantan A, de Mattos A, Naftel D, Crosswy A, Kirklin J, Curtis J. Increasing referral for end-stage renal disease in prior extrarenal solid organ transplant recipients at a single center. Clinical Journal of American Society of Nephrology 1 (4): 832-836, 2006. de Mattos A, Prather J, Olyaei A, Shibagaki Y, Keith D, Mori M, Norman D, Becker T. Cardiovascular Events Following Renal Transplantation: Role of Traditional and Transplant Specific Risk Factors. Kidney International 70 (4), 757-764, 2006. de Mattos AM, Olyaei AJ, Prather JC, Golconda MS, Barry JM, and Norman DJ. Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation. Kidney International, 67: 714 - 720, 2005. Olyaei AJ, de Mattos AM, Bennett WM. Cardiovascular complications of immunosuppressive agents in renal transplant recipients. Expert Opinion on Drug Safety, 4(1):29-44, 2005. Hippen BE, de Mattos AM, Cook WJ, Kew CE, Gaston RS. CD20-positive infiltrates predict steroid-resistance and reduced renal allograft survival in acute cellular rejection. American Journal of Transplantation 5: 2248-2252, 2005. Keith DS, de Mattos AM, Golconda M, Prather J, Cantarovich M, Paraskevas S, Tchervenkov J, Norman DJ. Factors Associated with Improvement in Deceased Donor Renal Allograft Function in the 1990s. Journal of the American Society of Nephrology, 16: 1512-1521, 2005 Olyaei, AJ, de Mattos AM, Bennett, WM. Cardiovascular Disease in Kidney Transplant Recipients: Are Patients Truly Stable? Graft, 7 (3): 136-155, 2005. Taylor GS, Prather JC, Norman DJ, deMattos AM, Moglishetty G, Conlin MJ, Barry JM. Living unrelated donor renal transplantation: a single center experience. The Journal of Urology, 174: 223-225, 2005. |

